Prevention of the Cardiovascular and Renal Effects of Angiotensin II by Endothelin Blockade

Hypertension

Volumn 31, Issue 1, 1998, Pages 10-14

  Herizi, Abderraouf ^a   Jover, Bernard ^a   Bouriquet, Nathalie ^a   Mimran, Albert ^a  

^a Faculte de Medecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BOSENTAN; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ESSENTIAL HYPERTENSION; GENE EXPRESSION REGULATION; HEART WEIGHT; HORMONAL REGULATION; HUMAN; KIDNEY BLOOD FLOW; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0031941152     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.10     Document Type: Article

References (34)

1. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
2. 1 receptor. Am J Hypertens. 1992;5:276-280.
3. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzil P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
4. Miller PL, Rennke HG, Meyer TW. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol. 1991;261:F459-F465.
5. Zimbler MS, Pickering TG, Sos TA, Laragh JH. Proteinuria in renovascular hypertension and the effect of renal angioplasty. Am J Cardiol. 1987;59:406-408.
6. Crawford DC, Chobianan AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res. 1994;74:727-739.
7. Sung C-P, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther. 1994;271:429-437.
8. Dohi YA, Hahn WA, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992;19:131-137.
9. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19:753-757.
10. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
11. Kohno M, Horio T, Ikeda M, Yokokawa K, Fukui T, Yasunari K, Kurihara N, Takeda T. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 1992;42:860-866.
12. Bakris GL, Re RN. Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol. 1993;264:F937-F942.
13. Yoshida K, Yasujima, M, Kohzuki M, Kanazawa M, Yoshinaga K, Abe K. Endothelin-1 augments response to angiotensin II infusion in rats. Hypertension. 1992;20:292-297.
14. Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller, M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
15. Mimran A, Casellas D, Dupont M. Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat. Kidney Int. 1980;18:746-753.
16. Redon J, Baldo E, Lubre E, Bertolin V, Lozano JV, Miralles A, Pascual JM. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. Kidney Int. 1996;49(suppl 55):S81-S84.
17. Douglas SA, Gellai M, Ezekiel M, Ohlstein EH. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. J Hypertens. 1994;12:561-567.
18. Schricker K, Scholz H, Hamann M, Clozel M, Kramer BK, Kurtz A. Role of endogenous endothelins in the renin system of normal and two-kidney, one clip rats. Hypertension. 1995;25:1025-1029.
19. Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. J Cardiovasc Pharmacol. 1995;26(suppl 3):S456-S458.
20. Sventek P, Turgeon A, Garcia R, Schiffrin EL. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney, one clip Goldblatt hypertension. J Hypertens. 1996;14:57-64.
21. Li JS, Knafo L, Turgeon A, Garcia R, Schiffrin EL. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats. Am J Physiol. 1996;271:H88-H93.
22. A -receptor blockade in angiotensin II-induced hypertension. Hypertension. 1997;29:435-441.
23. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993;91:1367-1373.
24. Zou LX, Imig JD, Von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension. 1996;28:669-677.
25. Balakrishnan SM, Wang HD, Gopalakrishnan V, Wilson TW, McNeill JR. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension. 1996;28:806-809.
26. Chen L, McNeill JR, Wilson TW, Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: role of endothelin. Hypertension. 1995;26:83-88.
27. B receptor antagonist. Circulation. 1996;93:2068-2079.
28. Emofi T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.
29. Li J-S, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995;25:495-500.
30. Li J-S, Lariviere R, Schiffrin EL. Effect of non selective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension. 1994;24:183-188.
31. Anke J, Van Eekelen M, Phillips MI. Plasma angiotensin II levels at moment of drinking during angiotensin II intravenous infusion. Am J Physiol. 1988;255:R500-R506.
32. Fregly MJ, Paulding W, Rowland NE. Comparison of the dipsogenic responsiveness of Long-Evans and Sprague-Dawley rats. Physiol Behav. 1990;47:1187-1192.
33. Textor SC, Brunner HR, Gavras H. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism. Hypertension. 1981;3:269-276.
34. Samson WK, Murphy TC. Antidipsogenic actions of endothelins are exerted via the endothelin-A receptor in the brain. Am J Physiol. 1993;265:R1212-R1215.